A brief presentation of pharmacology on the topic " ANTICHOLINESTERASES " .
Includes Origin,USES, MECHANISM OF ACTION, SIDE EFFECTS , ADVERSE REACTIONS ,
A PowerPoint presentation on Anti Muscarinic drugs it has a broad information on different drugs like Anti-Muscarinic drugs Anti-Nicotinic drugs and some information on Ganglionic blocking drugs with their general information including different brands, different generics, their pictures, dosage, side effort and treatment measures etc.
May this information may be helpful to you.
Regards.
SYED MASOOD AHMED QUADRI
A PowerPoint presentation on Anti Muscarinic drugs it has a broad information on different drugs like Anti-Muscarinic drugs Anti-Nicotinic drugs and some information on Ganglionic blocking drugs with their general information including different brands, different generics, their pictures, dosage, side effort and treatment measures etc.
May this information may be helpful to you.
Regards.
SYED MASOOD AHMED QUADRI
Lecture covers the pharmacology of anticholinergic drugs. Includes classification, therapeutic uses, adverse effects of anticholinergics. Atropine has been described as prototype drug.
Drugs used in Parkinsons Disease ( anti- Parkinson drugs) Ravish Yadav
detail and complete study on the topic of anti parkinson drug. the study is done under the guidance of faculty member. the learning content complete information of the topic
Autacoids - pharmacological actions and drugs related to them. SIVASWAROOP YARASI
Autacoids or "autocoids" are biological factors which act like local hormones, have a brief duration, and act near the site of synthesis. The word autacoids comes from the Greek "autos" (self) and "acos" (relief, i.e. drug).
Dr. Jibachha Sah,M.V.Sc( Veterinary pharmacology, TU,Nepal),posted lecturer notes on AUTONOMIC AND SYSTEMIC PHARMACOLOGY for B.V.Sc & A.H. 6 th semester veterinary students of College of veterinary science,Nepal Polytechnique Institute, Bharatpur, Bhojard, Chitwan, Nepal.I hope this lecture notes may be beneficial for other Nepalese veterinary students. Please send your comment and suggestion .Email:jibachhashah@gmail.com,moble,00977-9845024121
Lecture covers the pharmacology of anticholinergic drugs. Includes classification, therapeutic uses, adverse effects of anticholinergics. Atropine has been described as prototype drug.
Drugs used in Parkinsons Disease ( anti- Parkinson drugs) Ravish Yadav
detail and complete study on the topic of anti parkinson drug. the study is done under the guidance of faculty member. the learning content complete information of the topic
Autacoids - pharmacological actions and drugs related to them. SIVASWAROOP YARASI
Autacoids or "autocoids" are biological factors which act like local hormones, have a brief duration, and act near the site of synthesis. The word autacoids comes from the Greek "autos" (self) and "acos" (relief, i.e. drug).
Dr. Jibachha Sah,M.V.Sc( Veterinary pharmacology, TU,Nepal),posted lecturer notes on AUTONOMIC AND SYSTEMIC PHARMACOLOGY for B.V.Sc & A.H. 6 th semester veterinary students of College of veterinary science,Nepal Polytechnique Institute, Bharatpur, Bhojard, Chitwan, Nepal.I hope this lecture notes may be beneficial for other Nepalese veterinary students. Please send your comment and suggestion .Email:jibachhashah@gmail.com,moble,00977-9845024121
- Application of drugs in body re medicines
- Bridges gap between laboratory science and medical practice
- Safety of prescribed medicine, maximise drug effects, minimise side effects
MYDRIATIC AND MIOTIC AGENTS AND DRUGS USED IN GLAUCOMA Rishabh Sharma
A brief Pathophysiology Presentation on the topic " MYDRIATIC AND MIOTIC AGENTS AND DRUGS USED IN GLAUCOMA "
Includes Both Open Angle and Closed Angle Glaucoma , their Mechanism Of Onset , Pathophysiology and Treatment ( Drugs Used In Glaucoma )
DIFFERENT METHODS OF PROTEIN ESTIMATION - PROTEINS AND ENZYMES ASSIGNMENTRishabh Sharma
A brief PROTEINS AND ENZYMES ASSIGNMENT on the topic - " DIFFERENT METHODS OF PROTEIN ESTIMATION " . Includes Methods, Applications, Uses and different techniques of protein estimation and separation . Separation on the basis of charge
ACID PHOSPHATASE - PROTEINS AND ENZYMES ASSIGNMENT Rishabh Sharma
A brief PROTEINS AND ENZYMES ASSIGNMENT on the topic - ACID PHOSPHATASE . Includes Properties, Reactions and Classification of Acid Phosphatases . Includes significance and functions of Aid Phosphatases as well.
(Monitoring Of Clinical Trial Assignment ) " Write about the factors that de...Rishabh Sharma
"Write about factors that determine the strategy of monitoring of Clinical Trials (Monitoring Of Clinical Trial Assignment )
Includes Extent and nature of monitoring , components of a monitoring plan , Documentation / Monitoring activities , Procedures of Monitoring , Importance of Monitoring Report , Factors to consider when developing a monitoring plan
Biopharmaceutics Presentation - A brief presentation on the topic- BCS Classification and it's role in formulation development . Includes uses of BCS Classification
CLINICAL BIOCHEMISTRY PRESENTATION ON HPLC- HIGH PERFORMANCE LIQUID CHROMATOG...Rishabh Sharma
A brief presentation of CLINICAL BIOCHEMISTRY on the topic HPLC- HIGH PERFORMANCE LIQUID CHROMATOGRAPHY
Includes :- Origin, Uses, Mechanism, Drawbacks,
A brief Presentation of Pharmacology on the Drug " Physostigmine " . Includes origin ,Indication, uses, treatment, trade name pharmacodynamics, side effects,
References -https://en.wikipedia.org/wiki/Physostigmine
Seminar of U.V. Spectroscopy by SAMIR PANDASAMIR PANDA
Spectroscopy is a branch of science dealing the study of interaction of electromagnetic radiation with matter.
Ultraviolet-visible spectroscopy refers to absorption spectroscopy or reflect spectroscopy in the UV-VIS spectral region.
Ultraviolet-visible spectroscopy is an analytical method that can measure the amount of light received by the analyte.
This pdf is about the Schizophrenia.
For more details visit on YouTube; @SELF-EXPLANATORY;
https://www.youtube.com/channel/UCAiarMZDNhe1A3Rnpr_WkzA/videos
Thanks...!
Multi-source connectivity as the driver of solar wind variability in the heli...Sérgio Sacani
The ambient solar wind that flls the heliosphere originates from multiple
sources in the solar corona and is highly structured. It is often described
as high-speed, relatively homogeneous, plasma streams from coronal
holes and slow-speed, highly variable, streams whose source regions are
under debate. A key goal of ESA/NASA’s Solar Orbiter mission is to identify
solar wind sources and understand what drives the complexity seen in the
heliosphere. By combining magnetic feld modelling and spectroscopic
techniques with high-resolution observations and measurements, we show
that the solar wind variability detected in situ by Solar Orbiter in March
2022 is driven by spatio-temporal changes in the magnetic connectivity to
multiple sources in the solar atmosphere. The magnetic feld footpoints
connected to the spacecraft moved from the boundaries of a coronal hole
to one active region (12961) and then across to another region (12957). This
is refected in the in situ measurements, which show the transition from fast
to highly Alfvénic then to slow solar wind that is disrupted by the arrival of
a coronal mass ejection. Our results describe solar wind variability at 0.5 au
but are applicable to near-Earth observatories.
Nutraceutical market, scope and growth: Herbal drug technologyLokesh Patil
As consumer awareness of health and wellness rises, the nutraceutical market—which includes goods like functional meals, drinks, and dietary supplements that provide health advantages beyond basic nutrition—is growing significantly. As healthcare expenses rise, the population ages, and people want natural and preventative health solutions more and more, this industry is increasing quickly. Further driving market expansion are product formulation innovations and the use of cutting-edge technology for customized nutrition. With its worldwide reach, the nutraceutical industry is expected to keep growing and provide significant chances for research and investment in a number of categories, including vitamins, minerals, probiotics, and herbal supplements.
The increased availability of biomedical data, particularly in the public domain, offers the opportunity to better understand human health and to develop effective therapeutics for a wide range of unmet medical needs. However, data scientists remain stymied by the fact that data remain hard to find and to productively reuse because data and their metadata i) are wholly inaccessible, ii) are in non-standard or incompatible representations, iii) do not conform to community standards, and iv) have unclear or highly restricted terms and conditions that preclude legitimate reuse. These limitations require a rethink on data can be made machine and AI-ready - the key motivation behind the FAIR Guiding Principles. Concurrently, while recent efforts have explored the use of deep learning to fuse disparate data into predictive models for a wide range of biomedical applications, these models often fail even when the correct answer is already known, and fail to explain individual predictions in terms that data scientists can appreciate. These limitations suggest that new methods to produce practical artificial intelligence are still needed.
In this talk, I will discuss our work in (1) building an integrative knowledge infrastructure to prepare FAIR and "AI-ready" data and services along with (2) neurosymbolic AI methods to improve the quality of predictions and to generate plausible explanations. Attention is given to standards, platforms, and methods to wrangle knowledge into simple, but effective semantic and latent representations, and to make these available into standards-compliant and discoverable interfaces that can be used in model building, validation, and explanation. Our work, and those of others in the field, creates a baseline for building trustworthy and easy to deploy AI models in biomedicine.
Bio
Dr. Michel Dumontier is the Distinguished Professor of Data Science at Maastricht University, founder and executive director of the Institute of Data Science, and co-founder of the FAIR (Findable, Accessible, Interoperable and Reusable) data principles. His research explores socio-technological approaches for responsible discovery science, which includes collaborative multi-modal knowledge graphs, privacy-preserving distributed data mining, and AI methods for drug discovery and personalized medicine. His work is supported through the Dutch National Research Agenda, the Netherlands Organisation for Scientific Research, Horizon Europe, the European Open Science Cloud, the US National Institutes of Health, and a Marie-Curie Innovative Training Network. He is the editor-in-chief for the journal Data Science and is internationally recognized for his contributions in bioinformatics, biomedical informatics, and semantic technologies including ontologies and linked data.
20. Side effects :-
The anticholinesterases are associated with prominent
gastrointestinal adverse effects,
particularly anorexia, nausea and vomiting.
21. Precautions when taking Anticholinesterases
Care should be taken when using these medications in patients
with:
Asthma and chronic obstructive airways disease – may increase
shortness of breath.
Cardiac conduction abnormalities – anticholinesterases can slow
the heart
Peptic ulcer – Because of their pharmacological action,
cholinesterase inhibitors may be expected to increase gastric acid
secretion.
23. • ABOUT THE OWNER/ CREATOR:-
BACHELOR'S STUDENT AT JAMIA HAMDARD (CLINICAL RESEARCH) WITH
EXPERIENCE IN CLINICAL RESEARCH
• WITH FOCUS ON GOOD CLINICAL PRACTICES AND DRUG REGULATIONS AND
DRUG EVENTS MANAGEMENT, PHARMACODYNAMICS AND
PHARMACOKINETICS.